Microbot medical inc. (MBOT)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Operating activities:
Net loss

-7,247

-7,260

-7,589

-9,663

-921

-1,206

-26,439

-28,491

-21,328

-25,243

-27,026

Adjustments to reconcile net loss to net cash flows from operating activities:
Interest and amortization of discount on convertible notes

-

-

237

333

-7

-

-

-

-

-

-

Share-based transaction costs incurred in reverse recapitalization

-

-

-

7,258

0

-

-

-

-

-

-

Total income and expense items not involving cash flows

-

-

-

-

-

202

-

-

-

-

-

Financing loss on debt extinguishment

-

-

-2,364

0

-

-

-

-

-

-

-

Changes in fair value of derivative warrant liability

-

-

-

-262

-

-

-

-

-

-

-

Amortization of debt discount and issuance costs

-

-

-

-

-

-

288

-

-

-

-

Gain on disposal of fixed assets

-

-

-

-

-

-

38

-20

-32

10

-

Write-down of fixed assets

-

-

-

-

-

-

-

27

-

62

-

Impairment of intangible asset

-

-

-

-

-

-

-

-

654

-

-

Loss on disposal of intangible assets relating to discontinued operations

-

-

-

-

-

-

-

-

-

-67

-

Gain from settlement agreement, net

-

-

-

-

-

-

-

-

-

226

-

Gain on sale of marketable securities

-

-

-

-

-

-

-

-

83

-

406

Changes in fair value of derivative warrant liability

-

-

-285

-

0

-

-3,253

5,944

-6,612

-

-

Depreciation and amortization

84

54

-

-

-

-

1,058

991

1,207

1,520

1,694

Shares issued to a vendor

-

74

-

-

-

-

-

-

-

-

-

Non cash and accrued interest

-25

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

21

10

17

16

-

-

-

-

-

Capital gain from sales of property and equipment

96

-

-

-

-

-

-

-

-

-

-

Share-based compensation expense

1,099

1,399

479

676

0

186

2,608

2,878

3,260

3,929

4,203

Changes in assets and liabilities:
Increase in restricted cash

-

-

-

0

-

-

-

-

-

-

-

Adjustments required to present cash flows from operating activities (Appendix A)

-

-

-

-

-

143

-

-

-

-

-

Prepaid expenses and other assets

126

40

-

-

-

-

-801

-22

-495

437

-129

Account payables and other accrued liabilities

-140

463

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-3

50

-67

39

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

3,005

1,898

Other receivables

-

-

14

-538

-66

31

298

-39

78

-550

-275

Other payables and accrued liabilities

-

-

-69

324

66

-

-

-

-

-

-

Deposits and other long-term liabilities

-

-

-

-

-

-

-

-

-

69

-

Net cash flows from operating activities

-6,451

-5,310

-4,856

-786

-765

-

-23,322

-19,869

-22,058

-24,519

-24,682

Investing activities:
Proceeds from sales of marketable equity securities

-

-

-

-

-

-

-

-

-

-

510

Advance made under note receivable

-

-

-

-

-

-

-

-

-

-

79

Purchase of property and equipment

216

223

58

25

2

11

4,680

73

296

923

701

Sales or maturities of marketable debt securities

-

-

-

-

-

-

14,430

5,762

6,905

-

8,994

Proceeds from sales of marketable security

-

-

-

-

-

-

-

-

158

-

-

Exercise of warrants issued upon conversion of notes

-

-

-

409

0

-

-

-

-

-

-

Exercise of warrants

-

-

-

-

-

-

530

6,256

-

-

331

Deposit for operational leasing

-

-

-

-

-

3

-

-

-

-

-

Sales of property and equipment

259

-

-

-

-

-

38

-

-

-

-

Other assets

-

-

-

-

-

-

-493

-89

-76

-601

436

Accounts payable and accrued expenses

-

-

-

-

-

-

2,143

-409

130

-808

477

Accrued wind-down expense

-

-

-

-

-

-

1,102

1,032

1,165

1,202

1,027

Deferred revenue

-

-

-

-

-

-

-24

13

-18

-79

-361

Deferred rent

-

-

-

-

-

-

435

85

1,302

129

306

Net cash used for operating activities

-

-

-

-

-

-1,063

-

-

-

-

-

Purchase of marketable security

2,496

-

-

-

-

-

687

16,380

10,188

-

4,976

Acquisition of other assets

-

-

-

-

-

-

64

-

-

-

-

Purchase of intangibles and other assets

-

-

-

-

-

-

-

-

-

-

15

Net cash flows from investing activities

-2,453

-223

-58

-25

-2

-

9,035

-10,691

-3,422

-923

3,731

Financing activities:
Acquisition of a subsidiary in connection with reverse recapitalization

-

-

-

269

0

-

-

-

-

-

-

Transaction costs incurred in reverse recapitalization

-

-

-

-347

0

-

-

-

-

-

-

Outflow (inflow) in connection with current assets and liabilities acquired in reverse recapitalization, net

-

-

-

-2,002

-

-

-

-

-

-

-

Inflows in connection with current assets and liabilities acquired in reverse recapitalization, net

-

-

317

-

0

-

-

-

-

-

-

Deferred financing fees

-

18

-

-

-

-

-

-

-

-

-

Net cash used for investment activities

-

-

-

-

-

-7

-

-

-

-

-

Issuance of common stock and warrants, net of issuance costs

36,770

-

12,702

0

-

1,502

23,491

19,747

19,774

7,279

29,602

Issuance of convertible notes

-

-

-

750

413

-

-

-

-

-

-

Repayment of loan payable

-

-

-

-

-

-

-

-

176

-

-

Net cash flows from financing activities

36,770

-18

13,019

3,083

413

-

36,402

25,737

19,129

6,586

29,786

Increase (decrease) in cash, cash equivalents and restricted cash

27,866

-5,551

8,105

2,272

-

-

-

-

-

-

-

Increase (decrease) in trade payables

-

-

-

-

-

-19

-

-

-

-

-

Increase (decrease) in other payables

-

-

-

-

-

-7

-

-

-

-

-

Total changed in assets and liabilities

-

-

-

-

-

58

-

-

-

-

-

Adjustments required to present cash flows from operating activities (Appendix A)

-

-

-

-

-

143

-

-

-

-

-

Interest paid

-

-

-

-

-

-

427

50

71

93

110

Non-cash activities:
Right-of-use assets obtained in exchange for new operating lease obligations

966

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-354

-

-

-4,824

-6,350

-18,857

8,835

Repayment of debt obligations

-

-

-

-

-

-

826

191

-

-

-

Payments related to net share issuance of stock based awards

-

-

-

-

-

-

342

59

403

483

380

Repayment of capital lease obligations

-

-

-

-

-

-

12

20

67

68

-128

Proceeds from the exercise of stock options

-

-

-

-

-

-

3

3

2

19

252

Proceeds from loan payable

-

-

-

-

-

-

13,558

-

-

-

-

Repayment of loan payable

-

-

-

-

-

-

-

-

-

161

149

Net cash generated by financing activities

-

-

-

-

-

1,502

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

431

22,116

-

-

-

-

Effects of foreign exchange rate changes on cash

-

-

-

-

-

-

-2

-15

-45

-52

-260

Supplemental disclosure of cash flow information:
Cash received from interest

97

-

-

-

-

-

-

-

-

-

-

Cashless exercise of warrants

-

-

-

0

-

-

-

-

-

-

-

Rescission of share purchase agreement

-

3,375

-

-

-

-

-

-

-

-

-

Conversion of Series A Convertible Preferred Stock into common stock

-

30

90

0

-

-

-

-

-

-

-

Financing fees included in other receivable

412

412

-

-

-

-

-

-

-

-

-

Extinguishment of convertible notes in exchange for Series A Convertible Preferred Stock

-

-

2,083

0

-

-

-

-

-

-

-

Temporary equity classified to permanent equity

-

500

-

-

-

-

-

-

-

-

-

Equipment acquired under a capital lease

-

-

-

-

-

-

43

21

-

-

-

Stock retired from settlement agreement (3)

-

-

-

-

-

-

-

-

-

241

-

Stock issued as part of our acquisition of the operations of SCS Plc(1)

-

-

-

-

-

-

-

-

-

-

4,425

Forgiveness of principal and accrued interest on notes receivable(1)

-

-

-

-

-

-

-

-

-

-

709

Stock issued for licensing agreements(2)

-

-

-

-

-

-

-

-

-

-

10